Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May 6;7:189.
doi: 10.3389/fmed.2020.00189. eCollection 2020.

Coronavirus Disease 2019 Emergency and Cancer in the South of Italy: What's New for the Oncologist?

Affiliations
Free PMC article

Coronavirus Disease 2019 Emergency and Cancer in the South of Italy: What's New for the Oncologist?

Concetta Ingenito et al. Front Med (Lausanne). .
Free PMC article

Abstract

No abstract available

Keywords: cancer; coronavirus disease; management; patients; treatment.

Similar articles

See all similar articles

References

    1. Remuzzi A, Remuzzi G. COVID-19 and Italy: what next? Lancet. (2020) 395:1225–8. 10.1016/S0140-6736(20)30627-9 - DOI - PMC - PubMed
    1. Landmann A, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet. (2020) 21:335–7. 10.1016/S1470-2045(20)30096-6. - DOI - PMC - PubMed
    1. Boehm K, et al. Telemedicine online visits in urology during COVID-19 pandemic - Potential, risk factors & patients' perspective. Eur Urol. (in press). - PMC - PubMed
    1. Marandino L, Di Maio M, Procopio G, Cinieri S, Beretta GD, Necchi A. The shifting landscape of genitourinary oncology during the COVID-19 pandemic and how Italian oncologists reacted: Results from a national survey. Eur Urol. (2020). 10.1016/j.eururo.2020.04.004. [Epub ahead of print]. - DOI - PMC - PubMed
    1. Zhang C, Wu Z, Li JW, Zhao H, Wang GQ. The cytokine release syndrome (CRS) of severe COVID-19 Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality. Int J Antimicrob Agents. (2020). 10.1016/j.ijantimicag.2020.105954. [Epub ahead of print]. - DOI - PMC - PubMed

LinkOut - more resources

Feedback